Discover open access scientific publications

Search, annotate, share and cite publications

Publications by D. Conklin

Dacomitinib (PF-00299804), an Irreversible Pan-Her Inhibitor, Inhibits Proliferation of HER2-Amplified Breast Cancer Cell Lines Resistant to Trastuzumab and Lapatinib

Molecular Cancer Therapeutics

Cancer Research

English